News & Highlights
-
Gap in reading levels may explain apparent differences in cognitive testing
December 15, 2001
The research of Jennifer Manly, PhD, and colleagues at Columbia University suggests that methodological and analytical approaches, not actual racial... -
Gap in reading levels may explain apparent differences in cognitive testing
December 15, 2001
The research of Jennifer Manly, PhD, and colleagues at Columbia University suggests that methodological and analytical approaches, not actual racial... -
Alzheimer's disease clinical trials expanded, expedited
September 20, 2001
As part of intensifying efforts to expand and expedite the search for Alzheimer's disease (AD) treatments, the National Institute on Aging (NIA)... -
Breakthrough mouse model for Alzheimer's more like human disease
August 23, 2001
In a breakthrough with important implications for research on Alzheimer's disease (AD), scientists at the Mayo Clinic Jacksonville (FL) have... -
Scientists zero in on enzyme at work in Alzheimer's disease
February 26, 2001
Experiments in a newly developed mouse model to determine which of two beta secretases in the brain might be principally responsible for developing... -
Scientists suspect new genetic risk factor for late onset Alzheimer's disease
December 21, 2000
Three new, separate research studies suggest that a gene or genes on chromosome 10 may be risk factors for late onset Alzheimer's disease (AD).... -
New study links head injury, severity of injury, with Alzheimer's disease
October 23, 2000
A new analysis of head injuries among World War II veterans links serious head injury in early adulthood with Alzheimer's disease (AD) in later... -
Nasal Alzheimer's vaccine successfully tested in mice
October 15, 2000
Nasal administration of synthetic beta amyloid peptide reduces potentially damaging Alzheimer's disease-like plaques in the brains of test mice... -
Low-dose prednisone found ineffective against Alzheimer's disease; researchers continue to look at NSAIDs, other drugs
February 7, 2000
A low-dose regimen of the steroid prednisone, an anti-inflammatory drug, is not effective in the treatment of Alzheimer's disease (AD), according... -
NIA to study COX-2 inhibitor, other NSAID as new treatment for Alzheimer's disease
February 7, 2000
The National Institute on Aging (NIA) is launching a clinical trial to determine whether treatment with certain nonsteroidal anti-inflammatory drugs... -
"Untangling" tau: New mouse model shows key feature of Alzheimer's disease
November 23, 1999
Scientists have succeeded in producing a hallmark of Alzheimer's disease in a laboratory animal model. The much-anticipated transgenic mouse... -
Gene that causes familial British dementia may yield clues to Alzheimer's disease
June 23, 1999
Researchers supported by the National Institute on Aging (NIA) have discovered a novel gene, which when mutated is responsible for familial British... -
Study furthers understanding of critical Alzheimer's disease gene
April 7, 1999
Researchers have cracked part of the code for an important gene function in familial Alzheimer's disease (FAD), an early-onset type of AD.... -
Questions and answers on launch of NIA memory impairment study
March 15, 1999
1. What is Mild Cognitive Impairment? Mild cognitive impairment (MCI) is a condition characterized by memory impairment with otherwise unaffected... -
Scientists discover new gene associated with Alzheimer's
February 27, 1998
University of Pittsburgh researchers supported by the National Institute on Aging (NIA) and the National Cancer Institute report in the March 1998... -
26 National Alzheimer's Disease Centers collaborate on study of the utility of genetic testing for Alzheimer's
February 18, 1998
Scientists at 26 Alzheimer's Disease Centers have collaborated on a study that concludes that a test for a form of an Alzheimer's-related... -
Estrogen replacement may help slow decline in memory in post-menopausal women
December 22, 1997
A new long-term study from the National Institute on Aging (NIA) suggests that use of estrogen replacement therapy (ERT) by post-menopausal women may... -
New study finds substance that helps working memory work better
June 9, 1997
The drug, physostigmine, when administered to people by infusion in laboratory tests, aids and improves performance of everyday working memory.... -
New drug therapies delay effects of Alzheimer's disease
April 23, 1997
Selegiline (or Eldepryl) and alpha-tocopherol (or Vitamin E) may slow important functional signs and symptoms of Alzheimer's disease by about 7... -
Low rates of Alzheimer's disease found in Cherokee Indians
October 14, 1996
The degree to which Cherokee Indians are of pure ancestry or mixed ancestry may play a role in delaying the development of Alzheimer's disease after...
Pages
Questions? Contact ADEAR
Call to talk to an Information Specialist:
1-800-438-4380 (toll-free)
Mon-Fri, 8:30 am-5:00 pm Eastern Time
or send an email to: adear@nia.nih.gov
